You are viewing articles tagged with "During 12/2015".

• Can we translate the results of SPRINT into clinical practice?

  The much awaited results of the Systolic Blood Pressure Intervention Trial (SPRINT) have recently been published.

  Read More 15/12/2015

• 

  Renew your ISH 2016 membership

  Receive your annual subscription to the Journal of Hypertension, substantial savings on registration fees for the ISH Biennial Scientific Meetings and much more.

  Read More 10/12/2015

• 

  An interview with Amit Tirosh - ISH December new investigator of the month

  Amit is a Senior Endocrinologist at Rabin Medical Center, Israel. Visiting attending endocrinologist, National Institutes of Health. He is interested in the diagnosis of hypercortisolism, and in the prevention of its deleterious effects, including hypertension, hyperglycemia and hypercoagulability.

  Read More 02/12/2015

• 

  Sex, drugs and trials galore

  We are delighted to present you with the December 2015 issue of ISH Hypertension News.
  This includes coverage of the results of four trials, all of which have important implications for clinical practice in relation to improving CVD prevention. Three of these trials - SPRINT and two PATHWAYS trials - have clinical implications for hypertension management (how low to go and how to do it) and one EMPA-REG provides unique data regarding optimal glucose lowering with a new class of agents for the prevention of CVD in patients with type 2 diabetes!

  Read More 02/12/2015